ATE394489T1 - Streptococcus antigene - Google Patents

Streptococcus antigene

Info

Publication number
ATE394489T1
ATE394489T1 AT99960748T AT99960748T ATE394489T1 AT E394489 T1 ATE394489 T1 AT E394489T1 AT 99960748 T AT99960748 T AT 99960748T AT 99960748 T AT99960748 T AT 99960748T AT E394489 T1 ATE394489 T1 AT E394489T1
Authority
AT
Austria
Prior art keywords
streptococcus antigens
streptococcus
antigens
Prior art date
Application number
AT99960748T
Other languages
English (en)
Inventor
Josee Hamel
Bernard Brodeur
Isabelle Pineau
Denis Martin
Clement Rioux
Nathalie Charland
Original Assignee
Id Biomedical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22351610&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE394489(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Id Biomedical Corp filed Critical Id Biomedical Corp
Application granted granted Critical
Publication of ATE394489T1 publication Critical patent/ATE394489T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C07K14/3156—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Communicable Diseases (AREA)
  • Neurosurgery (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT99960748T 1998-12-23 1999-12-20 Streptococcus antigene ATE394489T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11380098P 1998-12-23 1998-12-23

Publications (1)

Publication Number Publication Date
ATE394489T1 true ATE394489T1 (de) 2008-05-15

Family

ID=22351610

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99960748T ATE394489T1 (de) 1998-12-23 1999-12-20 Streptococcus antigene

Country Status (29)

Country Link
EP (2) EP1141306B1 (de)
JP (2) JP4761623B2 (de)
KR (4) KR100891398B1 (de)
CN (3) CN101134775A (de)
AP (1) AP2001002199A0 (de)
AR (1) AR029322A1 (de)
AT (1) ATE394489T1 (de)
AU (1) AU1764900A (de)
BR (1) BR9916477A (de)
CA (1) CA2356836C (de)
CL (1) CL2009002037A1 (de)
CY (3) CY1108223T1 (de)
CZ (2) CZ303675B6 (de)
DE (1) DE69938670D1 (de)
DK (3) DK1141306T3 (de)
EA (1) EA007409B1 (de)
ES (3) ES2400280T3 (de)
HU (1) HU229664B1 (de)
IL (3) IL143905A0 (de)
MX (1) MXPA01006427A (de)
NO (1) NO330800B1 (de)
NZ (1) NZ512574A (de)
OA (1) OA11736A (de)
PL (3) PL204073B1 (de)
PT (3) PT2261358E (de)
TR (2) TR200102497T2 (de)
UY (1) UY25877A1 (de)
WO (1) WO2000039299A2 (de)
ZA (1) ZA200105114B (de)

Families Citing this family (79)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1054971B1 (de) 1998-02-20 2006-12-06 ID Biomedical Corporation Gruppe b-streptococcus antigene
EP1801218A3 (de) * 1998-07-27 2007-10-10 Sanofi Pasteur Limited Nukleinsäuren und Proteine aus Pneumokokken
US20030134407A1 (en) 1998-07-27 2003-07-17 Le Page Richard William Falla Nucleic acids and proteins from Streptococcus pneumoniae
PT1140157E (pt) * 1998-12-21 2009-05-06 Medimmune Inc Proteínas de streptococcus pneumoniae e fragmentos imunogénicos para vacinas
US7128918B1 (en) 1998-12-23 2006-10-31 Id Biomedical Corporation Streptococcus antigens
PT2261358E (pt) * 1998-12-23 2014-07-30 Id Biomedical Corp Quebec Antigénios de streptococcus
US6866855B2 (en) 2000-06-12 2005-03-15 University Of Saskatchewan Immunization of dairy cattle with GapC protein against Streptococcus infection
PT1294771E (pt) 2000-06-12 2009-01-06 Univ Saskatchewan Proteína gapc quimérica de streptococcus e sua utilização em vacinação e diagnóstico
US6833134B2 (en) 2000-06-12 2004-12-21 University Of Saskacthewan Immunization of dairy cattle with GapC protein against Streptococcus infection
US7074415B2 (en) 2000-06-20 2006-07-11 Id Biomedical Corporation Streptococcus antigens
EA006232B1 (ru) 2000-06-20 2005-10-27 Ай Ди Биомедикал Корпорейшн Стрептококковые антигены
WO2002079475A2 (en) * 2001-03-30 2002-10-10 Shire Biochem Inc. Streptococcus pyogenes antigens and corresponding dna fragments
DE60234772D1 (de) 2001-07-06 2010-01-28 Id Biomedical Corp Gruppe-b streptococcus antigene und entsprechende dna-fragmente
GB0130228D0 (en) * 2001-12-18 2002-02-06 Hansa Medica Ab Protein
US7262024B2 (en) 2001-12-20 2007-08-28 Id Biomedical Corporation Streptococcus antigens
DE602004022923D1 (de) * 2003-03-04 2009-10-15 Intercell Ag Streptococcus pyogenes antigene
CA2522238A1 (en) * 2003-04-15 2004-10-28 Intercell Ag S. pneumoniae antigens
DK2384765T3 (en) 2005-12-22 2017-01-09 Glaxosmithkline Biologicals Sa Vaccine against Streptococcus pneumoniae.
GB0607088D0 (en) 2006-04-07 2006-05-17 Glaxosmithkline Biolog Sa Vaccine
PL2167121T3 (pl) 2007-06-26 2016-01-29 Glaxosmithkline Biologicals Sa Szczepionka zawierająca koniugaty polisacharydu otoczkowego streptococcus pneumoniae
CN101802198B (zh) * 2007-07-23 2016-02-17 圣诺菲·帕斯图尔有限公司 免疫原性多肽和单克隆抗体
ES2553113T3 (es) 2008-04-16 2015-12-04 Glaxosmithkline Biologicals S.A. Vacuna
US8962026B2 (en) 2008-09-26 2015-02-24 The Regents Of The University Of Michigan Nanoemulsion therapeutic compositions and methods of using the same
WO2010125480A1 (en) 2009-04-30 2010-11-04 Coley Pharmaceutical Group, Inc. Pneumococcal vaccine and uses thereof
US8668911B2 (en) 2009-05-14 2014-03-11 The Regents Of The University Of Michigan Streptococcus vaccine compositions and methods of using the same
MY163512A (en) 2009-09-03 2017-09-15 Pfizer Vaccines Llc Pcsk9 vaccine
GB201003920D0 (en) * 2010-03-09 2010-04-21 Glaxosmithkline Biolog Sa Method of treatment
JP6046632B2 (ja) 2010-12-03 2016-12-21 サノフィ パストゥール リミテッドＳａｎｏｆｉ Ｐａｓｔｅｕｒ Ｌｉｍｉｔｅｄ 肺炎球菌に対する免疫用組成物
MY163871A (en) * 2011-01-20 2017-10-31 Genocea Biosciences Inc Vaccines and compositions against streptococcus pneumoniae
US20140004142A1 (en) 2011-03-02 2014-01-02 Pfizer Inc. Pcsk9 vaccine
BR112013029514A2 (pt) 2011-05-17 2019-09-24 Glaxosmithkline Biologicals Sa composição imunogênica, vacina, e, método de tratar ou impedir uma doença
EP2800580B1 (de) * 2012-01-05 2017-07-12 Deutsches Krebsforschungszentrum Peptide für die behandlung und diagnose von idh1 r132h positiven krebsarten
CA2894903A1 (en) * 2012-12-14 2014-06-19 Sanofi Pasteur, Ltd. Methods for assessing immunogenicity
US11160855B2 (en) 2014-01-21 2021-11-02 Pfizer Inc. Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
NZ721943A (en) 2014-01-21 2022-07-01 Pfizer Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
US20160324949A1 (en) 2014-01-21 2016-11-10 Pfizer Inc. Streptococcus pneumoniae capsular polysaccharides and conjugates thereof
RU2710393C2 (ru) 2014-01-21 2019-12-26 Пфайзер Инк. Способ получения иммуногенного конъюгата капсульный полисахарид Streptococcus pneumoniae-белок-носитель
EP3443983B1 (de) 2014-02-14 2022-07-20 Pfizer Inc. Immunogene glykoproteinkonjugate
IL252915B2 (en) 2015-01-15 2024-04-01 Pfizer Immunogenic compositions for use in pneumococcal vaccines
TWI756893B (zh) 2015-07-21 2022-03-01 美商輝瑞股份有限公司 包含經共軛之莢膜糖抗原的致免疫性組成物、包含該致免疫性組成物之套組及彼等之用途
GB201518684D0 (en) 2015-10-21 2015-12-02 Glaxosmithkline Biolog Sa Vaccine
JP6884145B2 (ja) 2015-11-20 2021-06-09 ファイザー・インク 肺炎連鎖球菌ワクチンにおいて用いるための免疫原性組成物
GB201610599D0 (en) 2016-06-17 2016-08-03 Glaxosmithkline Biologicals Sa Immunogenic Composition
AU2018208844B2 (en) 2017-01-20 2021-02-25 Pfizer Inc. Immunogenic compositions for use in pneumococcal vaccines
US11260119B2 (en) 2018-08-24 2022-03-01 Pfizer Inc. Escherichia coli compositions and methods thereof
EP3893926A1 (de) 2018-12-12 2021-10-20 Pfizer Inc. Immunogene multiple hetero-antigen-polysaccharid-protein-konjugate und deren verwendung
JP7239509B6 (ja) 2019-02-22 2023-03-28 ファイザー・インク 細菌多糖類を精製するための方法
CA3136278A1 (en) 2019-04-10 2020-10-15 Pfizer Inc. Immunogenic compositions comprising conjugated capsular saccharide antigens, kits comprising the same and uses thereof
CN114728050A (zh) 2019-07-31 2022-07-08 圣诺菲·帕斯图尔公司 多价肺炎球菌多糖-蛋白质缀合物组合物及其使用方法
MX2022005252A (es) 2019-11-01 2022-06-08 Pfizer Composiciones de escherichia coli y metodos de las mismas.
EP4107192A1 (de) 2020-02-21 2022-12-28 Pfizer Inc. Reinigung von sacchariden
BR112022014555A2 (pt) 2020-02-23 2022-09-20 Pfizer Composições de escherichia coli e métodos das mesmas.
CA3199094A1 (en) 2020-10-22 2022-04-28 Pfizer Inc. Methods for purifying bacterial polysaccharides
US12138302B2 (en) 2020-10-27 2024-11-12 Pfizer Inc. Escherichia coli compositions and methods thereof
WO2024110839A2 (en) 2022-11-22 2024-05-30 Pfizer Inc. Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
CA3199610A1 (en) 2020-10-27 2022-05-05 Pfizer Inc. Escherichia coli compositions and methods thereof
KR20230097160A (ko) 2020-11-04 2023-06-30 화이자 인코포레이티드 폐렴구균 백신에 사용하기 위한 면역원성 조성물
US12357681B2 (en) 2020-12-23 2025-07-15 Pfizer Inc. E. coli FimH mutants and uses thereof
WO2022234405A1 (en) 2021-05-03 2022-11-10 Pfizer Inc. Vaccination against bacterial and betacoronavirus infections
WO2022234416A1 (en) 2021-05-03 2022-11-10 Pfizer Inc. Vaccination against pneumoccocal and covid-19 infections
EP4346893A2 (de) 2021-05-28 2024-04-10 Pfizer Inc. Immunogene zusammensetzungen mit konjugierten kapselsaccharidantigenen und verwendungen davon
KR20230175284A (ko) 2021-05-28 2023-12-29 화이자 인코포레이티드 접합된 피막 사카라이드 항원을 포함하는 면역원성 조성물 및 그의 용도
IL314243A (en) 2022-01-13 2024-09-01 Pfizer Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
WO2023161817A1 (en) 2022-02-25 2023-08-31 Pfizer Inc. Methods for incorporating azido groups in bacterial capsular polysaccharides
CA3256617A1 (en) 2022-05-11 2023-11-16 Pfizer Inc. PROCESS FOR PRODUCING VACCINE FORMULATIONS WITH PRESERVATIVES
WO2024084397A1 (en) 2022-10-19 2024-04-25 Pfizer Inc. Vaccination against pneumoccocal and covid-19 infections
WO2024110827A1 (en) 2022-11-21 2024-05-30 Pfizer Inc. Methods for preparing conjugated capsular saccharide antigens and uses thereof
EP4626405A1 (de) 2022-12-01 2025-10-08 Pfizer Inc. Pneumokokkenkonjugat-impfstoffformulierungen
WO2024166008A1 (en) 2023-02-10 2024-08-15 Pfizer Inc. Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
CN121038808A (zh) 2023-03-30 2025-11-28 辉瑞公司 包含缀合的荚膜糖抗原的免疫原性组合物及其用途
WO2024214016A1 (en) 2023-04-14 2024-10-17 Pfizer Inc. Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
WO2024224266A1 (en) 2023-04-24 2024-10-31 Pfizer Inc. Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
WO2024241172A2 (en) 2023-05-19 2024-11-28 Glaxosmithkline Biologicals Sa Methods for eliciting an immune response to respiratory syncycial virus and streptococcus pneumoniae infection
WO2025057078A1 (en) 2023-09-14 2025-03-20 Pfizer Inc. Adjuvanted immunogenic compositions comprising conjugated pneumococcal capsular saccharide antigens and uses thereof
WO2025133971A1 (en) 2023-12-23 2025-06-26 Pfizer Inc. Improved methods for producing bacterial capsular saccharide glycoconjugates
WO2025186705A2 (en) 2024-03-06 2025-09-12 Pfizer Inc. Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
WO2025191415A1 (en) 2024-03-11 2025-09-18 Pfizer Inc. Immunogenic compositions comprising conjugated escherichia coli saccharides and uses thereof
WO2025219908A2 (en) 2024-04-19 2025-10-23 Pfizer Inc. Media and fermentation methods for polysaccharide production in bacterial cell culture
WO2025219904A1 (en) 2024-04-19 2025-10-23 Pfizer Inc. Improved methods for producing glycoconjugates by reductive amination in aprotic solvent

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4431739A (en) 1979-11-05 1984-02-14 Genentech, Inc. Transformant bacterial culture capable of expressing heterologous protein
US4425437A (en) 1979-11-05 1984-01-10 Genentech, Inc. Microbial polypeptide expression vehicle
US4338397A (en) 1980-04-11 1982-07-06 President And Fellows Of Harvard College Mature protein synthesis
HU217582B (hu) * 1993-03-19 2000-02-28 Gunnar Lindahl Streptococcus B csoportba tartozó törzsek elleni immunitást biztosító, Rib fehérjenevű felületi protein, eljárás a protein tisztítására, reagenskészlet és gyógyszerkészítmény
CA2224015A1 (en) * 1995-06-07 1996-12-19 Biochem Vaccines Inc. Streptococcal heat shock proteins members of the hsp70 family
US5882896A (en) * 1996-09-24 1999-03-16 Smithkline Beecham Corporation M protein
US5928895A (en) * 1996-09-24 1999-07-27 Smithkline Beecham Corporation IgA Fc binding protein
EP0942983B2 (de) * 1996-10-31 2014-09-10 Human Genome Sciences, Inc. Streptococcus pneumoniae antigene und impfstoffe
BR9812525A (pt) * 1997-09-24 2000-07-25 Univ Minnesota Proteinase degradadora de complemento humano c3 de streptococcus pneumoniae
EP1073450A4 (de) * 1998-04-23 2003-04-23 Uab Research Foundation Pneumokokkales oberflächenprotein c (pspc), epitopische regionen, selelktion von entsprechenden stämmen und verwendungen
WO2000006738A2 (en) * 1998-07-27 2000-02-10 Microbial Technics Limited NUCLEIC ACIDS AND PROTEINS FROM $i(STREPTOCOCCUS PNEUMONIAE)
ATE361365T1 (de) * 1998-07-27 2007-05-15 Sanofi Pasteur Ltd Streptococcus pneumoniae proteine und nukleinsäuren
JP2002526082A (ja) * 1998-09-24 2002-08-20 リージェンツ オブ ザ ユニバーシティ オブ ミネソタ ストレプトコッカス・ニューモニア由来のヒト補体ｃ３分解ポリペプチド
PT1140157E (pt) * 1998-12-21 2009-05-06 Medimmune Inc Proteínas de streptococcus pneumoniae e fragmentos imunogénicos para vacinas
PT2261358E (pt) * 1998-12-23 2014-07-30 Id Biomedical Corp Quebec Antigénios de streptococcus

Also Published As

Publication number Publication date
CA2356836C (en) 2011-09-13
CA2356836A1 (en) 2000-07-06
KR100802198B1 (ko) 2008-02-11
KR101170203B1 (ko) 2012-07-31
KR100891398B1 (ko) 2009-04-02
PT2261358E (pt) 2014-07-30
KR101078919B1 (ko) 2011-11-01
EP2261358A3 (de) 2011-02-23
HK1118575A1 (en) 2009-02-13
PT1141306E (pt) 2008-07-30
EP1141306A2 (de) 2001-10-10
MXPA01006427A (es) 2002-06-04
CN100398653C (zh) 2008-07-02
OA11736A (en) 2005-06-12
IL194230A (en) 2013-12-31
CY1108223T1 (el) 2014-02-12
CY1114722T1 (el) 2016-10-05
KR20060134227A (ko) 2006-12-27
CN1654657A (zh) 2005-08-17
EP2261358B1 (de) 2014-05-14
IL143905A (en) 2011-05-31
DK2261358T3 (da) 2014-07-28
JP4761623B2 (ja) 2011-08-31
NO20013045D0 (no) 2001-06-19
ES2480417T3 (es) 2014-07-28
CZ303675B6 (cs) 2013-02-27
JP2002533123A (ja) 2002-10-08
JP5039802B2 (ja) 2012-10-03
NZ512574A (en) 2004-03-26
TR200102497T2 (tr) 2002-01-21
PT1950302E (pt) 2013-01-16
DK1141306T3 (da) 2008-08-18
KR20100063814A (ko) 2010-06-11
KR20010104693A (ko) 2001-11-26
AU1764900A (en) 2000-07-31
EA007409B1 (ru) 2006-10-27
EP2261358A2 (de) 2010-12-15
KR20080036666A (ko) 2008-04-28
UY25877A1 (es) 2000-08-21
TR200200633T2 (tr) 2002-06-21
IL194230A0 (en) 2011-08-01
IL143905A0 (en) 2002-04-21
HU229664B1 (en) 2014-04-28
NO20013045L (no) 2001-08-20
PL205041B1 (pl) 2010-03-31
EA200100565A1 (ru) 2002-04-25
CZ302790B6 (cs) 2011-11-09
EP1141306B1 (de) 2008-05-07
DE69938670D1 (de) 2008-06-19
AR029322A1 (es) 2003-06-25
JP2010142246A (ja) 2010-07-01
BR9916477A (pt) 2004-06-22
PL204073B1 (pl) 2009-12-31
DK1950302T3 (da) 2013-01-14
HUP0104774A3 (en) 2007-10-29
NO330800B1 (no) 2011-07-18
CN1191362C (zh) 2005-03-02
CN1332803A (zh) 2002-01-23
PL206576B1 (pl) 2010-08-31
WO2000039299A3 (en) 2000-11-02
CY1115340T1 (el) 2017-01-04
WO2000039299A2 (en) 2000-07-06
HUP0104774A2 (hu) 2002-04-29
AP2001002199A0 (en) 2001-09-30
ES2306528T3 (es) 2008-11-01
PL349777A1 (en) 2002-09-09
ZA200105114B (en) 2002-11-21
CZ20012161A3 (cs) 2001-10-17
CL2009002037A1 (es) 2010-06-25
CN101134775A (zh) 2008-03-05
ES2400280T3 (es) 2013-04-08

Similar Documents

Publication Publication Date Title
ATE394489T1 (de) Streptococcus antigene
ATE347600T1 (de) Gruppe b-streptococcus antigene
NO983141L (no) Antigene peptider
IL153558A0 (en) Streptococcus antigens
NO985464D0 (no) Konsentrert antistoffpreparat
DE69816852D1 (de) Zyklonabscheider
DE69804995D1 (de) Zyklonabscheider
DE69833154D1 (de) Mikrovorrichtung
DE69813177D1 (de) Heissschmelz-tintenstraltintezusammensetzung
DE69820169D1 (de) Synchronisiereinrichtung
DE69805093D1 (de) Zyklonabscheider
DE69802156D1 (de) Synchronisiereinrichtung
DE19948444B4 (de) Dämpfer
DE69801079D1 (de) Synchronisiereinrichtung
DE69800959D1 (de) Synchronisiereinrichtung
DE69801031D1 (de) Synchronisiereinrichtung
NO20005141D0 (no) Streptokokkpreparat
GB9825184D0 (en) Antigen
FR2776324B1 (fr) Bungalow cyclonique
GB9800760D0 (en) Antigens
NO951061D0 (no) Antistoffkonjugater med forbedrede egenskaper
GB0028727D0 (en) Streptococcus antigens
GB0026333D0 (en) Streptococcus antigens
GB9822143D0 (en) Antigens
GB9819015D0 (en) Antigens

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1141306

Country of ref document: EP